Trend — Injection, ublituximab-xiiy, 1mg (J2329) in Medicare, the United States
Trend · J2329 · National · CY2024
Twelve-year services series · J2329 · the United Statesincluded in Explore
The full twelve-year services and payments series for this market — per-year values, with the FFS-enrollment denominator beside each.
Compound growth · endpointsincluded in Explore
The compound annual growth for J2329 in the United States — endpoints exclude the introduction year; an Exclude 2020–21 view drops the pandemic years too.